Jacobs Levy Equity Management
ZY

Jacobs Levy Equity Management’s Zymergen Inc. Common Stock ZY Stock Holding History

Jacobs Levy Equity Management’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-128,480
Closed -$371K – 1132
2022
Q1 		$371K Buy
+128,480
New +$546K ﹤0.01% 898

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

Jacobs Levy Equity Management's ZY Position: Q2 2022 in Review

Jacobs Levy Equity Management sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 128,480 shares — an estimated $371K sold.

Jacobs Levy Equity Management first reported a position in ZY in Q1 2022 and held it in 1 quarter. The position peaked at $371K in Q1 2022. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

  • Jacobs Levy Equity Management reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 128,480 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $371K.
  • Jacobs Levy Equity Management first reported a position in Zymergen Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Zymergen Inc. Common Stock position peaked at $371K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2022, filed 15 Aug 2022.